Riskpilot← Back to searchSign inGet full accessHermitage Medical AB
ABActiveOrg 5591092928Medical specialists activities · NACE 8622Est. 20172 employees
Revenue 2025
SEK 736K
-28% vs 2024
EBITDA margin
83.6%
-18% vs 2024
Equity ratio
75.2%
Financial strength
Net profit 2025
SEK 794K
+24% vs 2024
| Revenue | SEK 736K | -28% |
| EBITDA | SEK 615K | -18% |
| Net profit | SEK 794K | +24% |
| Total assets | SEK 7,8M | +5% |
| Equity | SEK 5,9M | +11% |
| Employees | 2 | — |
Legal name
Hermitage Medical AB
Org number
5591092928
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
20 april 2017
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget skall bedriva läkarkonsultverksamhet inom hälso- och sjukvård, främst inom psykiatri, erbjuda utbildning och rådgivning och därmed förenlig verksamhet.
Address
Email
olgnez@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 148 | 1 052 | 1 009 | 1 026 | 736 |
| Staff expenses | — | — | — | — | −6 |
| EBITDA | 1 013 | 947 | 875 | 754 | 615 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 1 013 | 947 | 875 | 754 | 615 |
| Net financials | −1 | — | 5 | 5 | 2 |
| Profit before tax | 753 | 708 | 768 | 831 | 1 013 |
| Tax | −160 | −149 | −167 | −188 | −219 |
| Net profit | 593 | 559 | 601 | 643 | 794 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 274 | 6 027 | 6 822 | 7 456 | 7 822 |
| Equity | 3 497 | 4 056 | 4 656 | 5 299 | 5 884 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 188 | 142 | 224 | 286 | 464 |
| Total debt | 188 | 142 | 224 | 286 | 464 |
EBITDA margin
83.6%
This company
15.8%
Market median
+429% vs market
20212025
Equity ratio
75.2%
This company
38.2%
Market median
+97% vs market
20212025
Return on equity
13.5%
This company
18.4%
Market median
+27% vs market
20212025
Net profit margin
107.9%
This company
8.1%
Market median
+1232% vs market
20212025
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20212025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hermitage Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexander Valdman | Deputy Board Member | 0 companies |
| Olga Neznanova | Board of Directors | 0 companies |